PSYCHOTHERAPY FOR ADOLESCENTS, CHildren AND ADULTS
In response to the opioid crisis, researchers at Hospital for Special Surgery (HSS) are looking for alternate ways to reduce pain after orthopedic procedures.
Based on these findings, the team is planning a much larger, randomized clinical trial to compare it to standard opioid treatment.
Read morePsychedelic Science 2023 brought together 12,000 registrants in Denver, Colorado, four times as many people as the previous conference in 2017, crowning the movement to rehabilitate psychedelics for therapeutic use against depression and other disorders.
Read moreThis pilot study demonstrated the safety, feasibility, and possible efficacy of psilocybin-assisted group therapy for cancer patients dealing with depressive symptoms.
Read moreHere’s a review of two new books on the history of psychotropics.
Read moreThis ketamine trial for resistant depression shows positive results.
The study is the largest to date comparing generic ketamine with placebo in treating severe depression.
Read moreHere a UC researcher discusses how psychedelics show promise for treating PTSD and anxiety, but risks remain.
Read moreKeep reading for an interview with the patient thought to be the first person to receive psilocybin under Oregon’s new system. He discusses his psilocybin experience.
Read moreNew research from Compass Pathways says that:
“It has long been thought that SSRIs could interfere with the potential therapeutic effect of psilocybin.
This data is exciting because it provides a preliminary signal that this is not the case, and that patients could remain on their SSRI antidepressant medication and experience the same effect from COMP360 psilocybin treatment as people who are not on SSRIs.”
Keep reading for the history of the chemical imbalance theory, how a study last year tried to debunk it, and how that study is now seen to be flawed.
Read more